Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HYPERACT

Financiado

Quantitative HYpoxia imaging for charged ParticlE Radiation treatment guidance:...

Quantitative HYpoxia imaging for charged ParticlE Radiation treatment guidance: an improved strategy for Aggressive brain Cancers Treatment Glioblastoma and skull base chordoma are two of the most aggressive types of brain cancers and have an extremely poor prognosis, with most tumours recurring within months of surgical and chemoradiation treatments. Recurrence is ca... ver más

31/08/2026

POLIMI

189K€

Presupuesto del proyecto: 189K€

Líder del proyecto

POLITECNICO DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-27

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100% 100%

2 Participantes

POLIMI

188.59K€ | Lider

CNAO

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TIN2013-43457-R CARACTERIZACION DE FIRMAS BIOLOGICAS DE GLIOBLASTOMAS MEDIAN... 80K€ Cerrado

PLEC2022-009476 Advanced dosimetry for novel radiotherapy approaches in brai... 307K€ Cerrado

PDC2022-133383-I00 PLATAFORMA POTENCIADA POR IA PARA EL DIAGNOSTICO DE SUBTIPOS... 129K€ Cerrado

PID2021-128984OB-I00 OPTIMIZACION DE LA PRESCIPCION DE DOSIS Y LIMITES DE DOSIS-V... 48K€ Cerrado

MTM2012-31073 ONCOLOGIA MATEMATICA: MODELADO, ANALISIS, SIMULACION Y APLIC... 56K€ Cerrado

TED2021-130081B-C21 A COMPREHENSIVE COMPUTER-AIDED DIGANOSIS (CAD) SYSTEM BASED... 193K€ Cerrado

Duración del proyecto: 40 meses Fecha Inicio: 2023-04-27
Fecha Fin: 2026-08-31

Líder del proyecto

POLITECNICO DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 189K€

Descripción del proyecto Glioblastoma and skull base chordoma are two of the most aggressive types of brain cancers and have an extremely poor prognosis, with most tumours recurring within months of surgical and chemoradiation treatments. Recurrence is caused by tumour heterogeneity, as regions of the tumour with different biological properties respond differently to treatment. Tumour hypoxia (low oxygenation) is the leading cause of resistance to radiotherapy in heterogeneous cancers and is linked to poor patient prognosis. Effectively counteracting tumour hypoxia requires delivering higher doses of radiation selectively to hypoxic tumour regions. This is hard to achieve with conventional radiation treatment, where a uniform moderate radiation dose is delivered to the entire tumour target and dose-escalation strategies are limited by toxicity constraints established to limit damage to important surrounding brain structures. Standard radiotherapy plans do not incorporate any measure of tumour hypoxia, due to limitations in imaging techniques currently used for planning. The work proposed in this fellowship aims to improve radiation treatment for heterogeneous cancers by combining quantitative MRI/PET imaging, to non-invasively characterise regions of tumour hypoxia, and carbon ions radiotherapy, to deliver higher doses of radiation to those regions, whilst sparing surrounding healthy tissue. This strategy will deliver a more effective radiation dose distribution, providing an opportunity to improve local tumour control and patients’ survival outcomes and quality of life.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores